Position in AZN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$3,115,077
-$149,505 QoQ
Shares Held
16,428
-0.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
1.01%
of 13F equity value
Holder Rank
#454
of 1,459 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 88%
Shared 0%
None 12%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OARSMAN CAPITAL, INC. holds $20,990,952 across 10 Drug Manufacturers - General names. AZN ranks #3 (14.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
20,266 | $5,099,736 | |
| 2 | JNJ |
Johnson & Johnson
|
19,140 | $4,860,985 | |
| 3 | AZN |
Astrazeneca PLC
This page
|
16,428 | $3,115,077 | |
| 4 | LLY |
ELI LILLY & Co
|
2,212 | $2,653,139 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
42,777 | $2,464,810 | |
| 6 | AMGN |
Amgen Inc
|
2,694 | $975,551 | |
| 7 | NVS |
Novartis AG
|
4,006 | $627,820 | |
| 8 | PFE |
Pfizer Inc
|
23,471 | $565,181 |
All Filings in AZN
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,115,077 | 16,428 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $3,264,582 | 16,553 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,633,242 | 28,644 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||